title: Low risk of hepatitis B virus reactivation in patients with resolved infection and chronic myeloid leukemia treated with tyrosine kinase inhibitors.
authors.affiliation: a Department of Hematology , Catholic University of Sacred Heart , Rome , Italy.
authors.forename: Federica
authors.initials: F
authors.lastname: Sorà
authors.affiliation: b Department of Internal Medicine and Gastroenterology , Catholic University of Sacred Heart , Rome , Italy.
authors.forename: Francesca Romana
authors.initials: FR
authors.lastname: Ponziani
authors.affiliation: a Department of Hematology , Catholic University of Sacred Heart , Rome , Italy.
authors.forename: Luca
authors.initials: L
authors.lastname: Laurenti
authors.affiliation: a Department of Hematology , Catholic University of Sacred Heart , Rome , Italy.
authors.forename: Patrizia
authors.initials: P
authors.lastname: Chiusolo
authors.affiliation: a Department of Hematology , Catholic University of Sacred Heart , Rome , Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Autore
authors.affiliation: b Department of Internal Medicine and Gastroenterology , Catholic University of Sacred Heart , Rome , Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Gasbarrini
authors.affiliation: a Department of Hematology , Catholic University of Sacred Heart , Rome , Italy.
authors.forename: Simona
authors.initials: S
authors.lastname: Sica
authors.affiliation: b Department of Internal Medicine and Gastroenterology , Catholic University of Sacred Heart , Rome , Italy.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Pompili
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015897:Comorbidity; D005260:Female; D006509:Hepatitis B / Q000150:complications* / Q000453:epidemiology / Q000821:virology*; D006510:Hepatitis B Antibodies / Q000097:blood / Q000276:immunology; D006515:Hepatitis B virus / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy; D015994:Incidence; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D012189:Retrospective Studies; D019562:Viral Load; D014775:Virus Activation / Q000187:drug effects* / Q000276:immunology
chemical_list: D000970:Antineoplastic Agents; D006510:Hepatitis B Antibodies; D047428:Protein Kinase Inhibitors